Apr-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Beneleaves has demonstrated a strong presence in the Ohio market, particularly in the Capsules category where it has consistently maintained the top position from January through April 2025. Despite a decline in sales from January to March, the brand experienced a slight recovery in April, indicating a potential stabilization or strategic adjustment. In contrast, the brand's performance in the Vapor Pens category has been more volatile, with rankings fluctuating between 52nd and 63rd place over the same period. This indicates a more competitive landscape or possibly a need for product differentiation or marketing efforts in this category.
In the Topical category, Beneleaves made a significant entry by securing the 6th position in both March and April 2025, suggesting a successful product launch or increased consumer interest in this segment. The absence of rankings in January and February implies that the brand was not in the top 30, highlighting a remarkable upward movement within a short span. This could be indicative of a strategic pivot or an expansion of their product line that resonated well with consumers. Such movements across categories provide insights into Beneleaves' adaptability and market strategies, offering a glimpse into their potential growth trajectories in the evolving cannabis market of Ohio.
Competitive Landscape
In the Ohio cannabis capsules market, Beneleaves has consistently maintained its position as the top-ranked brand from January to April 2025, showcasing its strong market presence and consumer preference. Despite fluctuations in sales figures, with a noticeable dip in February before recovering in March and April, Beneleaves has successfully outperformed its closest competitors. Butterfly Effect - Grow Ohio has consistently held the second rank, yet its sales figures remain significantly lower than Beneleaves, indicating a substantial lead in market share. Meanwhile, Main Street Health has maintained the third position, with sales figures that also trail behind those of Beneleaves. This consistent ranking and sales performance highlight Beneleaves' robust brand loyalty and effective market strategies, positioning it as a dominant force in the Ohio capsules category.
Notable Products
In April 2025, Beneleaves' top-performing product was the RSO Capsules 22-Pack (660mg) in the Capsules category, maintaining its number one rank from the previous month with a notable sales figure of 2504 units. The CBD/THC Entourage Effect Capsules 22-Pack (110mg CBD, 220mg THC, 339mg CBG, 321mg CBN, 303mg CBC) retained its second position, showing stable performance across the months. Hypnos Indica Capsules 11-Pack (440mg) held steady at the third rank, consistent with March 2025. The Hybrid RSO Capsules 11-Pack (110mg) and Grape Distillate Disposable (1g) entered the rankings in March and maintained fourth and fifth positions, respectively, in April. Overall, the rankings for Beneleaves products remained relatively stable with no major shifts in their positions from March to April 2025.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.